PLOS ONE: A Randomized Open-Label Trial of Artesunate- Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P. falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan
![Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/618f5366-326d-4aac-9d85-05c9687bd2d1/gr1_lrg.jpg)
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine
![Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial | Trials | Full Text Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial | Trials | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13063-020-04637-z/MediaObjects/13063_2020_4637_Fig1_HTML.png)
Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial | Trials | Full Text
![PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60afa7902fddea770036d6744ee84027545bd238/3-Figure1-1.png)
PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar
![Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa - Journal of the American Academy of Dermatology Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e4db88a9-95c1-49d9-98d9-d8fb1d6d9d68/gr1.jpg)
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa - Journal of the American Academy of Dermatology
![Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial - Seizure - European Journal of Epilepsy Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial - Seizure - European Journal of Epilepsy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f5b9964c-4331-4321-a712-8d6a65155a91/gr1_lrg.jpg)
Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial - Seizure - European Journal of Epilepsy
![Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/06/clinicaltrials-2-e1566478031946.jpg)
Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals
![Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e53ef392-4fec-49e2-b653-2896383e183d/gr1.gif)
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology
![A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41436-020-01006-8/MediaObjects/41436_2020_1006_Fig1_HTML.png)
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism | Genetics in Medicine
![Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol](https://bmjopen.bmj.com/content/bmjopen/3/7/e002902/F1.large.jpg)
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol
![Drug trials Learning Outcome: DESCRIBE THE USE OF OPEN LABEL, BLIND AND DOUBLE BLIND TESTS IN HUMAN TRIALS (HIGHER) AND THE USE OF PLACEBOS. - ppt download Drug trials Learning Outcome: DESCRIBE THE USE OF OPEN LABEL, BLIND AND DOUBLE BLIND TESTS IN HUMAN TRIALS (HIGHER) AND THE USE OF PLACEBOS. - ppt download](https://images.slideplayer.com/20/6050871/slides/slide_6.jpg)